Evaluation of Extended-Release Oxycodone Administered through Enteral Tubes for the Management of Pain in Patients with Head and Neck Cancer: A Case Series

References

• National Comprehensive Cancer Network. Adult cancer pain. 2019 Mar [accessed 2019 Sep 20]. https://www.nccn.org/professionals/physician_gls/pdf/pain.pdf.
   Google Scholar
• Epstein JB, Stewart KH. Radiation therapy and pain in patients with head and neck cancer. Eur J Cancer. 1993;29(3):191–9. doi:https://doi.org/10.1016/0964-1955(93)90022-7.
   Google Scholar
• Rose-Ped AM, Bellm LA, Epstein JB, Trotti A, Gwede C, Fuchs HJ. Complications of radiation therapy for head and neck cancers. The patient's perspective. Cancer Nurs. 2002;25(6):461–7. doi:https://doi.org/10.1097/00002820-200212000-00010.
   PubMed Web of Science ®Google Scholar
• Roxicodone® (oxycodone hydrochloride tablets). Newport, KY: Xanodyne Pharmaceuticals, Inc. 2008 [accessed 2019 Sept 20]. https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021011s002lbl.pdf.
   Google Scholar
• US Food and Drug Administration. FDA advisory committee briefing document: Xtampza® ER (extended-release oxycodone). 2015 [accessed 2019 Sep 20]. https://www.pharmamedtechbi.com/∼/media/SupportingDocuments/The PinkSheetDAILY/2015/September/Collegium_oxycodone_AC_company_brfg.pdf.
   Google Scholar
• OxyContin® (oxycodone HCl controlled-release) tablets. Stamford, CT: Purdue Pharma L.P. 2008 [accessed 2019 Sept 20]. https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/020553s059lbl.pdf.
   Google Scholar
• Mayock SP, Saim S, Fleming AB. In vitro drug release after crushing: evaluation of Xtampza® ER and other ER opioid formulations. Clin Drug Investig. 2017;37(12):1117–24. doi:https://doi.org/10.1007/s40261-017-0561-9.
   PubMed Web of Science ®Google Scholar
• Xtampza® (oxycodone extended-release) capsules. Cincinnati, OH: Patheon Pharmaceuticals. 2016 [accessed 2019 Sept 20]. https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208090s000lbl.pdf.
   Google Scholar
• Gudin J, Levy-Cooperman N, Kopecky EA, Fleming A. Comparing the effect of tampering on the oral pharmacokinetic profiles of two extended-release oxycodone formulations with abuse-deterrent properties. Pain Med. 2015;16(11):2142–51. doi:https://doi.org/10.1111/pme.12834.
   PubMed Web of Science ®Google Scholar
• Kuip E, Zandvliet M, Koolen S, Mathijssen R, van der Rijt C. A review of factors explaining variability in fentanyl pharmacokinetics; focus on implications for cancer patients. Br J Clin Pharmacol. 2017;83(2):294–313. doi:https://doi.org/10.1111/bcp.13129.
   PubMed Web of Science ®Google Scholar
• Duragesic® (fentanyl transdermal system). Titusville, NJ: Janssen Pharmaceuticals, Inc. 2018 [accessed 2019 Sep 20]. http://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/DURAGESIC-pi.pdf.
   Google Scholar
• Dolophine® Hydrochloride (methadone hydrochloride tablets). Columbus, OH: Roxane Laboratories, Inc. 2015 [accessed 2019 Sep 20]. https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/006134s038lbl.pdf.
   Google Scholar
• Bruce JY, Harmon G, Woo K, Yu M, Kiltz J, Witek ME, Harari PM, Kimple RJ. Methadone use during concurrent chemoradiation in patients with head and neck cancer. Int J Radiat Oncol. 2018;100(5):1403. doi:https://doi.org/10.1016/j.ijrobp.2017.12.247.
   Web of Science ®Google Scholar
• Haumann J, Geurts JW, van Kuijk SM, Kremer B, Joosten EA, van den Beuken-van Everdingen MH. Methadone is superior to fentanyl in treating neuropathic pain in patients with head-and-neck cancer. Eur J Cancer. 2016;65:121–9. doi:https://doi.org/10.1016/j.ejca.2016.06.025.
   PubMed Web of Science ®Google Scholar
• Fleming AB, Carlson DR, Varanasi RK, Grima M, Mayock SP, Saim S, Kopecky EA. Evaluation of an extended-release, abuse-deterrent, microsphere-in-capsule analgesic for the management of patients with chronic pain with dysphagia (CPD). Pain Pract. 2016;16(3):334–44. doi:https://doi.org/10.1111/papr.12280.
   PubMed Web of Science ®Google Scholar
• Markman JD, Meske D, Kopecky E, Vaughn B, O'Connor ML, Passik S. Analgesic efficacy, safety, and tolerability of a long-acting abuse-deterrent formulation of oxycodone for moderate-to-severe chronic low back pain in subjects successfully switched from immediate-release oxycodone. J Pain Res. 2018;11:2051–9. doi:https://doi.org/10.2147/JPR.S168836.
   PubMed Web of Science ®Google Scholar
• Katz N, Kopecky EA, O'Connor M, Brown RH, Fleming AB. A phase 3, multicenter, randomized, double blind, placebo-controlled safety, tolerability, and efficacy study of Xtampza® ER in patients with moderate-to-severe chronic low back pain. Pain. 2015;156(12):2458–67. doi:https://doi.org/10.1097/j.pain.0000000000000315.
   PubMed Web of Science ®Google Scholar
• Kopecky EA, Vaughn B, Lagasse S, O'Connor M. Tolerability, safety, and effectiveness of oxycodone DETERx in elderly patients ≥65 years of age with chronic low back pain: a randomized controlled trial. Drugs Aging. 2017;34(8):603–13. doi:https://doi.org/10.1007/s40266-017-0473-7.
   PubMed Web of Science ®Google Scholar
• Ling DC, Kabolizadeh P, Heron DE, Ohr JP, Wang H, Johnson J, Kubicek GJ. Incidence of hospitalization in patients with head and neck cancer treated with intensity-modulated radiation therapy. Head Neck. 2015;37(12):1750–5. doi:https://doi.org/10.1002/hed.23821.
   PubMed Web of Science ®Google Scholar
• Mason H, Derubeis MB, Foster JC, Taylor JM, Worden FP. Outcomes evaluation of a weekly nurse practitioner-managed symptom management clinic for patients with head and neck cancer treated with chemoradiotherapy. Oncol Nurs Forum. 2013;40(6):581–6. doi:https://doi.org/10.1188/13.ONF.40-06AP.
   PubMed Web of Science ®Google Scholar
• Dalal S, Bruera E. Pain management for patients with advanced cancer in the opioid epidemic era. Am Soc Clin Oncol Educ Book. 2019;39:24–35. doi:https://doi.org/10.1200/EDBK_100020.
   PubMedGoogle Scholar
• National Comprehensive Cancer Network. Head and neck cancers. 2019 Mar [accessed 2019 Sept 20]. https://www.nccn.org/professionals/physician_gls/pdf/head-and-neck.pdf.
   Google Scholar